Literature DB >> 23510472

Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-κB in lung cancer and in normal pulmonary tissues.

D Falcone1, L Gallelli, A Di Virgilio, L Tucci, M Scaramuzzino, R Terracciano, G Pelaia, R Savino.   

Abstract

OBJECTIVES: In this study, we have evaluated effects of 24-hour treatments with simvastatin or rosuvastatin on RAS protein, NF-κB and MMP expression in LC tissues obtained from 12 patients undergoing thoracic surgery.
MATERIALS AND METHODS: Normal and lung tumour tissues obtained from each sample were exposed to simvastatin (2.5-30 μm) or rosuvastatin (1.25-30 μm) and western blot analysis was then performed.
RESULTS: We documented increased expression of proteins, MMP-2, MMP-9 and NF-κB-p65 in LC tissues, with respect to normal tissues (P < 0.01). In the malignant tissues, simvastatin and rosuvastatin significantly (P < 0.01) and dose-dependently reduced RAS protein, MMP-2/9 and NF-κB-p65 expression.
CONCLUSIONS: In conclusion, our results suggest that simvastatin and rosuvastatin could play a role in LC treatment by modulation of RAS protein, MMP-2/9 and NF-κB-p65.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510472      PMCID: PMC6495807          DOI: 10.1111/cpr.12018

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  47 in total

1.  Early age at smoking initiation and tobacco carcinogen DNA damage in the lung.

Authors:  J K Wiencke; S W Thurston; K T Kelsey; A Varkonyi; J C Wain; E J Mark; D C Christiani
Journal:  J Natl Cancer Inst       Date:  1999-04-07       Impact factor: 13.506

Review 2.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

Review 3.  Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets.

Authors:  Panagiotis A Konstantinopoulos; Michalis V Karamouzis; Athanasios G Papavassiliou
Journal:  Nat Rev Drug Discov       Date:  2007-07       Impact factor: 84.694

Review 4.  Statins and cancer: A systematic review and meta-analysis.

Authors:  Jaana Kuoppala; Anne Lamminpää; Eero Pukkala
Journal:  Eur J Cancer       Date:  2008-08-15       Impact factor: 9.162

5.  Differences in plasma MMPs and TIMPs protein expression and chemotherapy response in patients with tobacco- or wood-smoke-induced lung cancer.

Authors:  Georgina Gonzalez-Avila; Javier Delgado; Daniel A Mendoza-Posada; Bettina Sommer; Carlos Ramos; Arnoldo Aquino-Galvez; Catalina Camacho
Journal:  Respiration       Date:  2012-03-22       Impact factor: 3.580

6.  Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells.

Authors:  G Pelaia; L Gallelli; T Renda; D Fratto; D Falcone; M Caraglia; M T Busceti; R Terracciano; A Vatrella; R Maselli; R Savino
Journal:  Cell Prolif       Date:  2012-10-10       Impact factor: 6.831

7.  A randomized phase II study of gefitinib plus simvastatin versus gefitinib alone in previously treated patients with advanced non-small cell lung cancer.

Authors:  Ji-Youn Han; Soo-Hyun Lee; Nam Jin Yoo; Lee Suk Hyung; Yoon Joo Moon; Tak Yun; Heung Tae Kim; Jin Soo Lee
Journal:  Clin Cancer Res       Date:  2011-03-15       Impact factor: 12.531

Review 8.  Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.

Authors:  Jim Dimitroulakos; Ian A Lorimer; Glenwood Goss
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

9.  Evaluation based on systematic review of epidemiological evidence among Japanese populations: tobacco smoking and total cancer risk.

Authors:  Manami Inoue; Ichiro Tsuji; Kenji Wakai; Chisato Nagata; Tetsuya Mizoue; Keitaro Tanaka; Shoichiro Tsugane
Journal:  Jpn J Clin Oncol       Date:  2005-06-29       Impact factor: 3.019

10.  Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun.

Authors:  Shiu-Chen Huang; Chi-Tang Ho; Shoei-Yn Lin-Shiau; Jen-Kun Lin
Journal:  Biochem Pharmacol       Date:  2004-11-23       Impact factor: 5.858

View more
  14 in total

1.  Simvastatin and nanofibrous poly(l-lactic acid) scaffolds to promote the odontogenic potential of dental pulp cells in an inflammatory environment.

Authors:  Diana G Soares; Zhanpeng Zhang; Fatma Mohamed; Thomas W Eyster; Carlos A de Souza Costa; Peter X Ma
Journal:  Acta Biomater       Date:  2017-12-30       Impact factor: 8.947

2.  Effects of ambrisentan in a patient affected by combined pulmonary fibrosis and emphysema and by severe pulmonary hypertension: clinical, functional, and biomolecular findings.

Authors:  Fernando Roccia; Benedetta Campolo; Luca Gallelli; Carmen Spaccarotella; Annalisa Mongiardo; Daniela Falcone; Rocco Savino; Girolamo Pelaia; Ciro Indolfi; Rosario Maselli
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

3.  Inactivation of the Ras/MAPK/PPARγ signaling axis alleviates diabetic mellitus-induced erectile dysfunction through suppression of corpus cavernosal endothelial cell apoptosis by inhibiting HMGCS2 expression.

Authors:  Zhuo Zhang; Hai-Yan Zhang; Ying Zhang; Hai Li
Journal:  Endocrine       Date:  2018-11-20       Impact factor: 3.633

4.  Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide.

Authors:  Luca Gallelli; Daniela Falcone; Monica Scaramuzzino; Girolamo Pelaia; Bruno D'Agostino; Maria Mesuraca; Rosa Terracciano; Giuseppe Spaziano; Rosario Maselli; Michele Navarra; Rocco Savino
Journal:  BMC Pharmacol Toxicol       Date:  2014-11-29       Impact factor: 2.483

5.  LncRNA-RMRP Acts as an Oncogene in Lung Cancer.

Authors:  Qingjun Meng; Mingming Ren; Yanguang Li; Xiang Song
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

6.  Identification of genes associated with matrix metalloproteinases in invasive lung adenocarcinoma.

Authors:  Weiqing Li; Xugang Zhang; Zhitian Li; Fusheng Jiang; Hongwei Zhao; Bo Wei
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

7.  Effects of high rosuvastatin doses on hepatocyte mitochondria of hypercholesterolemic mice.

Authors:  Juan C Díaz-Zagoya; Alejandro Marín-Medina; Alma M Zetina-Esquivel; Jorge L Blé-Castillo; Andrés E Castell-Rodríguez; Isela E Juárez-Rojop; Rodrigo Miranda-Zamora
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

8.  Fluvastatin influences hair color in C57BL/6 mice.

Authors:  Ryszard Galus; Krzysztof Włodarski; Jacek Malejczyk; Jarosław Jóźwiak
Journal:  Int J Mol Sci       Date:  2013-07-10       Impact factor: 5.923

Review 9.  Statins and cancers.

Authors:  Aleksandra Stryjkowska-Góra; Bożenna Karczmarek-Borowska; Tomasz Góra; Katarzyna Krawczak
Journal:  Contemp Oncol (Pozn)       Date:  2014-08-29

10.  Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.

Authors:  Xiaoming Bai; Jie Wang; Yan Guo; Jinshun Pan; Qinyi Yang; Min Zhang; Hai Li; Li Zhang; Juan Ma; Feng Shi; Wei Shu; Yipin Wang; Jing Leng
Journal:  Sci Rep       Date:  2014-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.